Schurdak M E, Randerath K
Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030.
Cancer Res. 1989 May 15;49(10):2633-8.
The environmental pollutant 7H-dibenzo(c,g)carbazole (DBC) has been shown to be a potent carcinogen in various mouse tissues, but displays an unusual degree of hepatocarcinogenicity. We have previously reported that in accord with this activity, mouse liver is the target organ for DBC-DNA binding, with total levels being up to 2700 times greater than in extrahepatic tissues after s.c. administration. To elaborate on this finding, we have directly compared the tissue distribution of DNA damage by three diverse aromatic carcinogens, DBC, benzo(a)pyrene (BP), and 2-acetylaminofluorene (AAF). Following a single topical, p.o., or s.c. administration of 80 mumol/kg of test compound to male BALB/c mice, a 32P-postlabeling assay showed the total number of DBC adducts in liver DNA to be 11-138 times that in kidney, lung, or skin DNA. The degree of hepatic adduction varied as a function of the route of administration, with the highest occurring after topical application and the lowest after s.c. injection. The tissue preference for AAF and BP adducts varied with the route of administration and was much less than for DBC adducts, except that topical application of BP gave DNA adduct levels in skin that were 91-218 times greater than in other tissues. For a given tissue and route of administration, DNA adduction by DBC was 1.7- to 950-fold greater than that by BP and AAF, except in skin where the level of DNA adducts from BP was 3 to 4 times that from DBC. We conclude that (a) DBC exhibits an exceptional and unique preference for liver DNA adduction after different routes of administration; (b) DBC is more potent overall than BP or AAF in causing tissue DNA damage; and (c) for each of the three carcinogens, the route of exposure is a much less important factor than the nature of the carcinogen in determining the tissue distribution of covalent DNA damage.
环境污染物7H-二苯并(c,g)咔唑(DBC)已被证明在多种小鼠组织中是一种强效致癌物,但具有不同寻常程度的肝癌致癌性。我们之前报道过,与此活性相符,小鼠肝脏是DBC与DNA结合的靶器官,皮下给药后肝脏中的总水平比肝外组织高出多达2700倍。为详细阐述这一发现,我们直接比较了三种不同芳香族致癌物DBC、苯并(a)芘(BP)和2-乙酰氨基芴(AAF)造成的DNA损伤的组织分布情况。给雄性BALB/c小鼠单次局部、口服或皮下给予80 μmol/kg的受试化合物后,32P后标记分析显示肝脏DNA中DBC加合物的总数是肾脏、肺或皮肤DNA中的11 - 138倍。肝脏加合程度随给药途径而变化,局部应用后最高,皮下注射后最低。AAF和BP加合物的组织偏好随给药途径而变化,且比DBC加合物小得多,不过局部应用BP后皮肤中的DNA加合物水平比其他组织高91 - 218倍。对于给定的组织和给药途径,除了皮肤中BP的DNA加合物水平是DBC的3至4倍外,DBC造成的DNA加合比BP和AAF高1.7至950倍。我们得出结论:(a) DBC在不同给药途径后对肝脏DNA加合表现出异常且独特的偏好;(b) DBC在导致组织DNA损伤方面总体上比BP或AAF更具效力;(c) 对于这三种致癌物中的每一种,在决定共价DNA损伤的组织分布方面,暴露途径比致癌物的性质重要性低得多。